跳至主要内容
临床试验/NCT06698263
NCT06698263尚未招募4 期

13-cis Retinoic Acid (Isotretinoin) and Sperm Production

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Millions of Sperm Per Ejaculate

研究概览

简要总结

This study aims to evaluate the effectiveness of weekly administration of isotretinoin (40 mg) in increasing sperm production in men with oligozoospermia, a condition characterized by a low sperm count. Participants will be randomized into two groups: one receiving isotretinoin and the other a placebo. The primary outcome will be the change in sperm production over 20 weeks of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Subjects will be infertile men (no pregnancy with partner with normal cycles and normal hysterosalpingogram despite >1 year of unprotected intercourse).
  • Abnormal sperm analyses with a total, motile sperm count of less than 10 million sperm as assessed by semen analysis on two occasions separated by one week.
  • Male patients aged 21-55 years
  • Affiliation with a social security system
  • Ability to provide informed consent

排除标准

  • -Men participating in another clinical trial
  • Clinically significant abnormal findings at screening
  • Known genetic infertility (e.g. Klinefelter syndrome or Y-chromosome microdeletions),
  • Hypogonadotropic hypogonadism (that might respond to gonadotropin injections),
  • Severe mental health problems requiring medications
  • Current therapy with retinoic acid (e.g. Accutane) or vitamin A.
  • History of psychiatric disorders (e.g., depression, suicidal tendencies).
  • Abnormal serum chemistry values according to local laboratory normal values which indicate liver or kidney dysfunction.
  • Men currently receiving tetracycline containing medications
  • Men who have used isotretinoin within eight weeks of the start of dosing
  • Men with elevated serum triglycerides

研究组 & 干预措施

Isotretinoin

Experimental

Isotretinoin (40 mg) orally, once per week for 20 weeks

干预措施: Isotretinoin (Drug)

control group

Placebo Comparator

Placebo identical in appearance and administration schedule.

干预措施: Control group (placebo) (Drug)

结局指标

主要结局

Millions of Sperm Per Ejaculate

时间窗: Months 24

Concentration calculation of Millions of sperm per ejaculate in men treated with 13-cis retinoic acid

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验